ArticleBioactive materials2026

Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis.

Qihang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.